Demand For Senior Housing Ticks Up As Sector Continues COVID Recovery

/in , /by

Demand for senior housing properties began recovering this quarter as vacancies dropped nationally and rent growth picked up across all four major care types.

According to a new report from Moody’s, Q2 vacancy for the asset class came in at 16.9%, still worse than the pre-COVID five-year average but 10 basis points below the peak of 17% earlier this year.

“It may be too early to say the stress has bottomed out, especially given the recent resurgence of the virus, but second quarter data did prompt a bit of optimism for the senior housing sector,” Moody’s economist Lu Chen writes, noting that the second quarter vacancy rate for independent living, memory care, and assisted living facilities all declined between 10 and 30 basis points, while the vacancy rate for skilled nursing properties remained flat.

Memory care facilities, which have been hardest hit by the pandemic, showed a vacancy decrease of 8.8%, ending the quarter at 19.9%. Assisted living and skilled nursing facilities vacancies ticked up 6.9% over the same period to 18.2% and 16.5% respectively, while the vacancy rate at independent living facilities ticked up 6.1% from 9.5% pre-pandemic to 15.9% in the second quarter of this year.

Rent growth has softened year-over-year, Chen says, since most senior housing properties post rent changes at the beginning of the year, but Moody’s data suggests that rent growth picked up across all care types. The assisted living sector posted the fastest year-over-year rent growth, followed by independent living facilities.

Meanwhile, net absorption increased into positive terrain for the first time since 2020. Memory care is back to Q1 2020 levels, while skilled nursing showed the biggest gains with 8,000 units absorbed so far this year.

“As a result of the weakness in sector fundamentals since the public health crisis, extended slowdown of new facilities coming to market is consistent with the increase in investor’s caution for senior housing,” Chen writes.

Moody’s is “cautiously optimistic” in its outlook for the sector, Chen says, citing Centers for Medicare and Medicaid Service data indicating that more than 83% of the nursing home residents are fully vaccinated. However, he notes just 26% of nursing home facilities across the US have hit the industry target of vaccinating 75% of their staff.

“Low vaccine rates among staff and residents in states such as Florida leaves the senior housing industry more vulnerable to the resurgence of the virus. Starting in the first week of July, there has been a noticeable uptick of confirmed cases among senior housing residents and staff,” Chen says. “With new mask and vaccination mandates starting to take place in many places, we will closely monitor how that’s shaping the industry demand and supply in the coming months.”

An analysis from JLL earlier this spring indicated the need to serve the middle-income population will increase, leading to opportunities for investors.

“Investors remain bullish on seniors housing and care investments,” said JLL Managing Director Zach Bowyer, MAI, head of Alternatives Asset Sectors, Valuation Advisory. “We anticipate market fundamentals to steadily improve and the market to re-stabilize between two and four years, depending on the location.”

 

Source: GlobeSt.

Ventas Inc. Completes $2.3 Billion Acquisition Of The New Senior Investment Group Inc.

/in /by

Ventas, Inc. and New Senior Investment Group Inc. announced that Ventas has completed its acquisition of New Senior in an all-stock transaction valued at approximately $2.3 billion, including New Senior debt assumed or repaid by Ventas.

Under the terms of the merger agreement, New Senior stockholders are entitled to receive 0.1561 shares of newly issued Ventas common stock for each share of New Senior common stock that they owned immediately prior to the effective time of the merger.

“The acquisition of the New Senior portfolio positions Ventas to capture the powerful senior housing upside at a cyclical inflection point, adds a high quality independent living portfolio in advantaged markets with positive supply and demand fundamentals, and builds on existing relationships with leading operators and our deep experience in independent living at an attractive valuation that is accretive to Ventas,” said Debra A. Cafaro, Ventas Chairman and CEO. “I commend Susan Givens and her excellent team for their professionalism and accomplishments.”

Ventas’s third quarter 2021 guidance issued on August 6, 2021 excluded any contribution or impact from the Transaction.

Effective today, shares of New Senior common stock will no longer be traded on the New York Stock Exchange.

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world’s foremost Real Estate Investment Trusts, Ventas’s portfolio of approximately 1,300 properties is buoyed by the demographic tailwind of a large and growing aging population. Ventas uses the power of capital to unlock the value of senior living communities, life science, research & innovation properties, medical office & outpatient facilities and other healthcare real estate, working with leading care providers, developers, research, educational and medical institutions, innovators and healthcare organizations. Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas stakeholders.

New Senior Investment Group Inc. is a real estate investment trust with a diversified portfolio of senior housing properties located across the United States. New Senior is one of the largest owners of senior housing properties, with 103 properties across 36 states.

 

Source: yahoo! finance

IVX Health, National Provider Of Outpatient Infusion Centers, Secures $100 Million Growth Investment To Accelerate New Market Expansion

/in , , /by

IVX Health, a national provider of outpatient infusion centers, announcedt the completion of a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies.

Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.

IVX Health offers an alternative to hospital-based infusion and injection services, transforming the patient experience by providing a superior level of service in a cost-effective, convenient site of care. Its local centers offer guaranteed private suites, large flat screen TVs, high-speed Wi-Fi, leather recliners with chairs for guests, and flexible, on-demand scheduling, including evening and weekend appointments.

Operating over 50 infusion centers across 16 markets, IVX Health will immediately utilize the funding to accelerate entry into new markets in 2022 and beyond as it seeks to fulfill its vision of becoming the nation’s preferred destination of pharmaceutical care for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, among others.

“Our primary goal has always been to provide world-class service and clinical excellence to the patients we serve,” said Doug Ghertner, CEO of IVX Health. “IVX and Great Hill both see an inflection point in infusion therapy, as the growth in diagnosed autoimmune conditions and trends toward patient choice have aligned with an uptick in innovative new therapies. Many patients are unfortunately still left with few options for receiving this life-changing care, often within a crowded infusion room of a hospital – and that’s where we come in. We are confident that Great Hill’s investment and deep domain expertise will help us address this shortage of care options by enabling IVX to bring our unique clinical model and patient-centered amenities to an even broader universe of patients.”

“IVX Health is disrupting a distinct and rapidly growing healthcare vertical – biologic infusion and injection therapy – in unique ways that are driving tangible efficiencies for the U.S. healthcare system as a whole,” said Mark Taber, a Managing Director at Great Hill Partners. “We are excited to play a strategic, supporting role in fueling IVX Health’s next phase of growth as it enters new markets and collaborates with other providers in the healthcare ecosystem to drive value while continuing to redefine the care experience for its patients and referring providers.”

In connection with the investment, Taber will join IVX Health’s Board of Directors. Taber brings decades of executive healthcare experience from his time as Managing Director at Great Hill and as a board member of various portfolio companies.

In addition to IVX Health, Great Hill’s portfolio of healthcare companies includes: RxBenefits, Quantum Health, Labor First, ParetoHealth, and Vatica Health. The announcement deepens Great Hill’s experience partnering with innovative healthcare companies to help them pursue their full potential, which includes the recently-sold company, PartsSource, a leading provider of medical parts and supplies procurement solutions for hospitals, outpatient clinics, and physician offices.

IVX Health’s capital raise builds on what has already been a banner year for the company, as it has achieved record milestones for opening new centers, caring for new patients, and entering new states. IVX Health was also named to the prestigious Modern Healthcare Best Places to Work list for a third consecutive year. The organization continues to maintain an industry-leading 97 Net Promoter Score from its patient population.

Evercore served as financial advisor to IVX Health and TripleTree, LLC served as financial advisor to Great Hill.

About IVX Health

IVX Health is a national provider of infusion and injection therapy for those with complex chronic conditions such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis and other conditions.

IVX Health’s national footprint of outpatient infusion centers are conveniently located in the communities where patients live and work. IVX Health’s experience-first model includes amenities such as flexible appointment scheduling with evening and weekend availability, guaranteed private suites, high-speed Wi-Fi, flat screen TVs with streaming TV and movies, and comfortable recliners with room for guests. For more information on IVX Health and its existing locations, visit www.ivxhealth.com.

About Great Hill Partners

Great Hill Partners is a Boston-based private equity firm targeting investments of $25 million to $500 million in high-growth companies across the software, digital commerce, financial technology, healthcare, and digital infrastructure sectors. Over the past two decades, Great Hill has raised nearly $8 billion of commitments and invested in more than 75 companies, establishing an extensive track record of building long-term partnerships with entrepreneurs and providing flexible resources to help middle-market companies scale. For more information, including a list of all Great Hill investments, visit www.greathillpartners.com.

 

Source: businesswire